Herein, we report on an 18-month-old female patient carrying a novel de novo heterozygous c.913A>G variant in exon 2 of NACC1 who presented with a complex clinical profile characterized by severe intellectual disability, profound developmental delay, epilepsy, and neurological developmental impairment. Here, NACC1 is linked to Global developmental delay.